PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-188.64%
Both yoy net incomes decline, with CRK at -92.91%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
11.84%
Lower deferred tax growth vs. CRK's 510.82%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-15.09%
Negative yoy SBC while CRK is 1.02%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-53.33%
Negative yoy working capital usage while CRK is 176.68%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-342.86%
Both yoy AR lines negative, with CRK at -1531.30%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-53.33%
Negative yoy usage while CRK is 190.61%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-24.19%
Negative yoy while CRK is 654.55%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
6.99%
Operating cash flow growth below 50% of CRK's 231.79%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-72.20%
Both yoy lines negative, with CRK at -117.44%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-99.23%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
1080.00%
Purchases growth of 1080.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
72.20%
Liquidation growth of 72.20% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-47.32%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-129.52%
We reduce yoy invests while CRK stands at 226.95%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
98.87%
Debt repayment growth of 98.87% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-84.91%
Negative yoy issuance while CRK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.